A Study of REPLAGAL® in Treatment-naive Chinese Participants With Fabry Disease

NCT04974749 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
20
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Takeda